The response-to-retention hypothesis of early atherogenesis.

Many processes have been implicated in early atherogenesis. These include endothelial denudation, injury, or activation, including shear stress–related events; local adherence of platelets; lipoprotein oxidation; lipoprotein aggregation; macrophage chemotaxis and foam cell formation; and smooth muscle cell alterations. Which process, if any, could be regarded as the key event in early atherogenesis, ie, absolutely required, yet also sufficient as the sole pathological stimulus in an otherwise normal artery to provoke a cascade of events leading to lesion formation? The work of many investigators, which we summarize here, strongly supports subendothelial retention of atherogenic lipoproteins as the central pathogenic process in atherogenesis (for prior reviews, see References 1 through 61 2 3 4 5 6 ). Our thesis is that other contributory processes are either not individually necessary or are not sufficient. Most often, they are merely normal, expected responses of otherwise-healthy tissue to the presence of retained lipoproteins. It is instructive to catalog other processes that have been argued to be central to the initiation of atherogenesis. The first is endothelial denudation,7 8 9 injury,10 or activation,11 12 as outlined in the “response-to-injury” hypothesis of Ross, Glomset, and coworkers. Although this important hypothesis has stimulated much of the work that we cite here, there is no definitive evidence in vivo that endothelial injury is either necessary or sufficient for lesion formation. The response-to-injury hypothesis originally presupposed endothelial desquamation as the key event in atherogenesis.7 8 9 It is now clear, however, that developing atheromata are covered by an intact endothelial layer throughout most stages of lesion progression: lipoprotein retention, fatty streak formation, and formation of advanced lesions.5 6 12 13 14 15 In humans, only the most complicated, ulcerated lesions lose their endothelial layer. Furthermore, in some experimental models, an intact endothelium is required …

[1]  D. Steinberg,et al.  Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes. , 1993, The Journal of clinical investigation.

[2]  T. Nikkari,et al.  Oxidized low‐density lipoprotein is chemotactic for arterial smooth muscle cells in culture , 1990, FEBS letters.

[3]  W D Wagner,et al.  Plasma low density lipoprotein accumulation in aortas of hypercholesterolemic swine correlates with modifications in aortic glycosaminoglycan composition. , 1986, Atherosclerosis.

[4]  G. Camejo,et al.  Interaction of low density lipoproteins with arterial proteoglycans. The role of charge and sialic acid content. , 1985, Atherosclerosis.

[5]  D. Bok,et al.  Lipoprotein (a) displays increased accumulation compared with low-density lipoprotein in the murine arterial wall. , 1994, Chemistry and physics of lipids.

[6]  H. Shimano,et al.  High-cholesterol diet-induced lipoproteins stimulate lipoprotein lipase secretion in cultured rat alveolar macrophages. , 1987, Biochimica et biophysica acta.

[7]  P. A. Mourão,et al.  Glycosaminoglycan fractions from human arteries presenting diverse susceptibilities to atherosclerosis have different binding affinities to plasma LDL. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[8]  N. Simionescu,et al.  In vitro formation of oxidatively-modified and reassembled human low-density lipoproteins: antioxidant effect of albumin. , 1993, Biochimica et biophysica acta.

[9]  E. Kruithof,et al.  Expression of LDL receptor-related protein/alpha 2-macroglobulin receptor in human normal and atherosclerotic arteries. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[10]  V. V. van Hinsbergh,et al.  Role of endothelial cells and their products in the modification of low-density lipoproteins. , 1986, Biochimica et biophysica acta.

[11]  M. Brown,et al.  Low density lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived from apoprotein E-enriched lipoproteins. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[12]  G. Gresham,et al.  Atherosclerosis induced in hypercholesterolaemic baboons by immunological injury; and the effects of intravenous polyunsaturated phosphatidyl choline. , 1971, Atherosclerosis.

[13]  T. Carew,et al.  Initiation of atherosclerotic lesions in cholesterol-fed rabbits. II. Selective retention of LDL vs. selective increases in LDL permeability in susceptible sites of arteries. , 1989, Arteriosclerosis.

[14]  G. Chisolm,et al.  Participation of the endothelium in the development of the atherosclerotic plaque. , 1986, Progress in lipid research.

[15]  R. Lees,et al.  Low-density lipoprotein modification and arterial wall accumulation in a rabbit model of atherosclerosis. , 1993, Biochemistry.

[16]  A. Gown,et al.  Fatty streak expansion and maturation in Watanabe Heritable Hyperlipemic and comparably hypercholesterolemic fat-fed rabbits. , 1987, Arteriosclerosis.

[17]  J. Campbell,et al.  Vascular smooth muscle phenotype and growth behaviour can be influenced by macrophages in vitro. , 1988, Atherosclerosis.

[18]  N. Simionescu,et al.  Prelesional Modifications of the Vessel Wall in Hyperlipidemic Atherogenesis , 1990, Annals of the New York Academy of Sciences.

[19]  G. Mills,et al.  The distribution and composition of serum lipoproteins in eighteen animals. , 1971, Comparative biochemistry and physiology. B, Comparative biochemistry.

[20]  M. Haberland,et al.  Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. , 1988, Science.

[21]  H. Hoff,et al.  Extracts of human atherosclerotic lesions can modify low density lipoproteins leading to enhanced uptake by macrophages. , 1988, Atherosclerosis.

[22]  U. Beisiegel Lipoprotein (a) in the arterial wall , 1991, European heart journal.

[23]  R. Ross,et al.  The pathogenesis of atherosclerosis (second of two parts). , 1976, The New England journal of medicine.

[24]  J. Labat-Robert,et al.  Interaction between fibronectin, proteoglycans and lipoproteins. , 1990, International journal of biological macromolecules.

[25]  D. L. Fry,et al.  Effect of endothelial integrity, transmural pressure, and time on the intimal-medial uptake of serum 125I-albumin and 125I-LDL in an in vitro porcine arterial organ-support system. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[26]  R. Zechner,et al.  Interaction of lipoprotein Lp(a) and low density lipoprotein with glycosaminoglycans from human aorta. , 1988, Arteriosclerosis.

[27]  I. Tabas,et al.  Sphingomyelinase enhances low density lipoprotein uptake and ability to induce cholesteryl ester accumulation in macrophages. , 1991, The Journal of biological chemistry.

[28]  U. Steinbrecher,et al.  Scavenger receptor-independent stimulation of cholesterol esterification in macrophages by low density lipoprotein extracted from human aortic intima. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[29]  G. Bondjers,et al.  Lipoprotein lipase in atherosclerosis: its presence in smooth muscle cells and absence from macrophages. , 1987, Journal of lipid research.

[30]  T. Kita,et al.  Hypercoagulable State in the Watanabe Heritable Hyperlipidemic Rabbit, an Animal Model for the Progression of Atherosclerosis , 1989, Thrombosis and Haemostasis.

[31]  P. Libby,et al.  Cytokines and growth factors in atherogenesis. , 1992, Archives of pathology & laboratory medicine.

[32]  C. Hirschberg,et al.  Molecular cloning and expression of a glycosaminoglycan N-acetylglucosaminyl N-deacetylase/N-sulfotransferase from a heparin-producing cell line. , 1994, The Journal of biological chemistry.

[33]  T. Carew,et al.  Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[34]  D. Albanes,et al.  The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. , 1994, The New England journal of medicine.

[35]  J. Goldstein,et al.  Teaching old dogmas new tricks , 1987, Nature.

[36]  G. Truskey,et al.  Characterization of sites with elevated LDL permeability at intercostal, celiac, and iliac branches of the normal rabbit aorta. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[37]  G. Walldius,et al.  Antioxidants and atherosclerosis progression: unresolved questions. , 1994, Current opinion in lipidology.

[38]  E. Quentin,et al.  A genetic defect in the biosynthesis of dermatan sulfate proteoglycan: galactosyltransferase I deficiency in fibroblasts from a patient with a progeroid syndrome. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[39]  T. V. van Berkel,et al.  Different fate in vivo of oxidatively modified low density lipoprotein and acetylated low density lipoprotein in rats. Recognition by various scavenger receptors on Kupffer and endothelial liver cells. , 1991, The Journal of biological chemistry.

[40]  J. Resau,et al.  Unesterified cholesterol-rich lipid particles in atherosclerotic lesions of human and rabbit aortas. , 1988, The American journal of pathology.

[41]  C. Bisgaier,et al.  Apolipoprotein E modulates low density lipoprotein retention by lipoprotein lipase anchored to the subendothelial matrix. , 1993, The Journal of biological chemistry.

[42]  M. Gimbrone,et al.  Shear stress selectively upregulates intercellular adhesion molecule-1 expression in cultured human vascular endothelial cells. , 1994, The Journal of clinical investigation.

[43]  S. Eisenberg,et al.  Lipoprotein lipase enhances binding of lipoproteins to heparan sulfate on cell surfaces and extracellular matrix. , 1992, The Journal of clinical investigation.

[44]  J. Brunzell,et al.  Prevention of raised low-density lipoprotein cholesterol in a patient with familial hypercholesterolaemia and lipoprotein lipase deficiency , 1993, The Lancet.

[45]  D. Bilheimer,et al.  Failure of a slow channel calcium antagonist, verapamil, to retard atherosclerosis in the Watanabe heritable hyperlipidemic rabbit: an animal model of familial hypercholesterolemia. , 1985, Journal of the American College of Cardiology.

[46]  S. Skarlatos,et al.  Uptake of exogenous free cholesterol induces upregulation of tissue factor expression in human monocyte-derived macrophages. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[47]  A. Scanu,et al.  A potential basis for the thrombotic risks associated with lipoprotein(a) , 1989, Nature.

[48]  L. Kjellén,et al.  cDNA cloning and sequencing of mouse mastocytoma glucosaminyl N-deacetylase/N-sulfotransferase, an enzyme involved in the biosynthesis of heparin. , 1994, The Journal of biological chemistry.

[49]  M. Klein,et al.  Lipoprotein lipase increases low density lipoprotein retention by subendothelial cell matrix. , 1992, The Journal of clinical investigation.

[50]  T. Carew,et al.  Autoradiographic analysis of the distribution of 125I-tyramine-cellobiose-LDL in atherosclerotic lesions of the WHHL rabbit. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[51]  J. Kastelein,et al.  Decreased resistance against in vitro oxidation of LDL from patients with familial defective apolipoprotein B-100. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[52]  J. Crouse Progress in coronary artery disease risk-factor research: what remains to be done? , 1984, Clinical chemistry.

[53]  E. Wayner,et al.  Partial characterization of leukocyte binding molecules on endothelial cells induced by minimally oxidized LDL. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[54]  N. Simionescu,et al.  Visualization of the binding, endocytosis, and transcytosis of low- density lipoprotein in the arterial endothelium in situ , 1983, The Journal of cell biology.

[55]  G. Bengtsson-Olivecrona,et al.  Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[56]  R. Ross,et al.  Response to injury and atherogenesis. , 1977, The American journal of pathology.

[57]  D. Schwenke,et al.  Influx, efflux, and accumulation of LDL in normal arterial areas and atherosclerotic lesions of white Carneau pigeons with naturally occurring and cholesterol-aggravated aortic atherosclerosis. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[58]  D. B. Zilversmit,et al.  Effect of cholesterol feeding on arterial lipolytic activity in the rabbit. , 1977, Atherosclerosis.

[59]  M. Ferguson,et al.  Apolipoprotein E localization in human coronary atherosclerotic plaques by in situ hybridization and immunohistochemistry and comparison with lipoprotein lipase. , 1994, The American journal of pathology.

[60]  J Olszewski,et al.  Cellular oxidation of low density lipoprotein is caused by thiol production in media containing transition metal ions. , 1993, Journal of lipid research.

[61]  I. Tabas,et al.  Macrophage foam cell lipoprotein(a)/apoprotein(a) receptor. Cell-surface localization, dependence of induction on new protein synthesis, and ligand specificity. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[62]  R. Ross,et al.  Cellular Interactions, Growth Factors, and Smooth Muscle Proliferation in Atherogenesis a , 1990, Annals of the New York Academy of Sciences.

[63]  R. Ross,et al.  Role of endogenous platelet-derived growth factor in arterial smooth muscle cell migration after balloon catheter injury. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[64]  G. Bondjers,et al.  Proteoglycans and lipoproteins in atherosclerosis , 1993 .

[65]  P. Spring,et al.  LDL accumulation in the grossly normal human iliac bifurcation and common iliac arteries. , 1989, Experimental and molecular pathology.

[66]  B. Nordestgaard,et al.  Aortic permeability to LDL as a predictor of aortic cholesterol accumulation in cholesterol-fed rabbits. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[67]  Craig E. Thomas,et al.  The influence of medium components on Cu(2+)-dependent oxidation of low-density lipoproteins and its sensitivity to superoxide dismutase. , 1992, Biochimica et biophysica acta.

[68]  O. Portman,et al.  Metabolism of sphingolipids by normal and atherosclerotic aorta of squirrel monkeys. , 1970, Journal of lipid research.

[69]  R. Silverstein,et al.  von Willebrand factor mediates platelet adhesion to virally infected endothelial cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[70]  A. Gown,et al.  Human atherosclerosis. IV. Immunocytochemical analysis of cell activation and proliferation in lesions of young adults. , 1993, The American journal of pathology.

[71]  R. Ross,et al.  The pathogenesis of atherosclerosis (first of two parts). , 1976, The New England journal of medicine.

[72]  C. Hamm,et al.  Effects of lipoprotein(a) on in vitro lysis of whole blood thrombi from healthy volunteers. , 1993, Thrombosis research.

[73]  T. Nikkari,et al.  Glycosaminoglycans in normal and atherosclerotic human coronary arteries. , 1986, Laboratory investigation; a journal of technical methods and pathology.

[74]  K. O. Mercurius,et al.  Stimulation of transcription factors NF kappa B and AP1 in endothelial cells subjected to shear stress. , 1994, Biochemical and biophysical research communications.

[75]  Z. Yang,et al.  Regulation of biosynthesis of the basic fibroblast growth factor binding domains of heparan sulfate by heparan sulfate-N-deacetylase/N-sulfotransferase expression. , 1993, The Journal of biological chemistry.

[76]  P. Davies,et al.  Mechanical stress mechanisms and the cell. An endothelial paradigm. , 1993, Circulation research.

[77]  E. B. Smith,et al.  Factors influencing the accumulation in fibrous plaques of lipid derived from low density lipoprotein. II. Preferential immobilization of lipoprotein (a) (Lp(a)). , 1990, Atherosclerosis.

[78]  J. Qiao,et al.  Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice. , 1994, The Journal of clinical investigation.

[79]  L. Romics,et al.  Binding of fibronectin to human lipoproteins. , 1989, Clinica chimica acta; international journal of clinical chemistry.

[80]  S. Pizzo,et al.  Lipoprotein (a) regulates plasmin generation and inhibition. , 1994, Chemistry and physics of lipids.

[81]  E. Rubin,et al.  Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice. , 1994, The Journal of clinical investigation.

[82]  M. Gimbrone,et al.  Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells. , 1994, The Journal of clinical investigation.

[83]  J. Rutledge,et al.  Lipoprotein lipase (LpL) affects low density lipoprotein (LDL) flux through vascular tissue: evidence that LpL increases LDL accumulation in vascular tissue. , 1994, Journal of lipid research.

[84]  D. Steinberg Antioxidants in the prevention of human atherosclerosis. Summary of the proceedings of a National Heart, Lung, and Blood Institute Workshop: September 5-6, 1991, Bethesda, Maryland. , 1992, Circulation.

[85]  M. Ferguson,et al.  Smooth muscle cell expression of extracellular matrix genes after arterial injury. , 1994, The American journal of pathology.

[86]  Y. Hannun,et al.  The sphingomyelin cycle and the second messenger function of ceramide. , 1994, The Journal of biological chemistry.

[87]  G. Dahlén,et al.  In vitro studies of the interaction of isolated Lp(a) lipoprotein and other serum lipoproteins with glycosaminoglycans , 1978, Clinical genetics.

[88]  S. Mao,et al.  Attenuation of atherosclerosis in a modified strain of hypercholesterolemic Watanabe rabbits with use of a probucol analogue (MDL 29,311) that does not lower serum cholesterol. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[89]  K. Hajjar,et al.  Lipoprotein (a) regulates plasminogen activator inhibitor-1 expression in endothelial cells. A potential mechanism in thrombogenesis. , 1991, The Journal of biological chemistry.

[90]  Y. Arad,et al.  Lipoprotein lipase-mediated uptake and degradation of low density lipoproteins by fibroblasts and macrophages. , 1992, The Journal of clinical investigation.

[91]  G. Bondjers,et al.  Binding of low density lipoproteins by proteoglycans synthesized by proliferating and quiescent human arterial smooth muscle cells. , 1993, The Journal of biological chemistry.

[92]  K. Dugi,et al.  Structure, function and role of lipoprotein lipase in lipoprotein metabolism. , 1994, Current opinion in lipidology.

[93]  D. B. Zilversmit Atherogenesis: a postprandial phenomenon. , 1979, Circulation.

[94]  D. Carey,et al.  Differential expression of transmembrane proteoglycans in vascular smooth muscle cells. , 1993, The Journal of biological chemistry.

[95]  A. Daugherty,et al.  Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. , 1994, The Journal of clinical investigation.

[96]  C F Dewey,et al.  Platelet-derived growth factor B chain promoter contains a cis-acting fluid shear-stress-responsive element. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[97]  A. Fogelman,et al.  An ultrastructural study of lipoprotein accumulation in cardiac valves of the rabbit. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[98]  H. Hoff,et al.  Lipoproteins Containing Apo B Extracted from Human Aortas Structure and Function a , 1985, Annals of the New York Academy of Sciences.

[99]  B. Halliwell,et al.  Albumin--an important extracellular antioxidant? , 1988, Biochemical pharmacology.

[100]  R. Lal,et al.  Shear stress-induced reorganization of the surface topography of living endothelial cells imaged by atomic force microscopy. , 1994, Circulation research.

[101]  Y. Morino,et al.  Protective effect of lipoproteins containing apoprotein A‐I on Cu2+ ‐ catalyzed oxidation of human low density lipoprotein , 1989, FEBS letters.

[102]  T. V. van Berkel,et al.  In vivo fate and scavenger receptor recognition of oxidized lipoprotein[a] isoforms in rats. , 1992, Journal of lipid research.

[103]  W. Wagner,et al.  Characterization of extracellular matrix proteoglycan transcripts expressed by vascular smooth muscle cells. , 1990, European journal of cell biology.

[104]  E. B. Smith,et al.  The relationship between plasma and tissue lipids in human atherosclerosis. , 1974, Advances in lipid research.

[105]  V. Ord,et al.  Abundant expression of apoprotein E by macrophages in human and rabbit atherosclerotic lesions. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[106]  Y. Marcel,et al.  Cu2(+)-mediated oxidation of dialyzed plasma: effects on low and high density lipoproteins and cholesteryl ester transfer protein. , 1991, Journal of lipid research.

[107]  G. Bondjers,et al.  Effect of proteoglycans on lipoprotein-cell interactions: possible contribution to atherogenesis , 1990 .

[108]  E. Unanue,et al.  Stimulation of nonlymphoid mesenchymal cell proliferation by a macrophage-derived growth factor. , 1981, Journal of immunology.

[109]  H. Arita,et al.  Intracellular localization of group II phospholipase A2 in rat vascular smooth muscle cells and its possible relationship to eicosanoid formation. , 1991, Biochimica et biophysica acta.

[110]  Elspeth B. Smith,et al.  HAEMOSTATIC FACTORS IN HUMAN AORTIC INTIMA , 1981, The Lancet.

[111]  M. Gimbrone,et al.  Vascular endothelium responds to fluid shear stress gradients. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[112]  P. Weissberg,et al.  Proliferation of human smooth muscle cells promoted by lipoprotein(a). , 1993, Science.

[113]  T. Carew,et al.  Initiation of atherosclerotic lesions in cholesterol-fed rabbits. I. Focal increases in arterial LDL concentration precede development of fatty streak lesions. , 1989, Arteriosclerosis.

[114]  R. Krauss,et al.  Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI , 1991, Nature.

[115]  P. Dicorleto,et al.  The role of the endothelium in atherogenesis , 1993 .

[116]  Qi Chen,et al.  Immunostaining of human autopsy aortas with antibodies to modified apolipoprotein B and apoprotein(a). , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[117]  A. Lusis,et al.  Minimally modified low density lipoprotein is biologically active in vivo in mice. , 1991, The Journal of clinical investigation.

[118]  D. Hajjar,et al.  Lipoprotein and albumin accumulation in reendothelialized and deendothelialized aorta. , 1984, The American journal of pathology.

[119]  Asundi Vk,et al.  Molecular characterization of vascular smooth muscle decorin: deduced core protein structure and regulation of gene expression. , 1992, European journal of cell biology.

[120]  M. Brown,et al.  A receptor-mediated pathway for cholesterol homeostasis. , 1986, Science.

[121]  R. Bergstrand,et al.  Affinity of LDL to a human arterial proteoglycan among male survivors of myocardial infarction , 1989, European journal of clinical investigation.

[122]  W. Insull,et al.  Effect of regenerated endothelium on lipid accumulation in the arterial wall. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[123]  P. Libby,et al.  Inducible expression of vascular cell adhesion molecule-1 by vascular smooth muscle cells in vitro and within rabbit atheroma. , 1993, The American journal of pathology.

[124]  A. Lusis,et al.  Interaction of monocytes with cocultures of human aortic wall cells involves interleukins 1 and 6 with marked increases in connexin43 message. , 1991, The Journal of clinical investigation.

[125]  G. Bondjers,et al.  Expression of lipoprotein lipase mRNA and secretion in macrophages isolated from human atherosclerotic aorta. , 1993, The Journal of clinical investigation.

[126]  N. Simionescu,et al.  Prelesional events in atherogenesis. Accumulation of extracellular cholesterol-rich liposomes in the arterial intima and cardiac valves of the hyperlipidemic rabbit. , 1986, The American journal of pathology.

[127]  J L Witztum,et al.  Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. , 1989, The Journal of clinical investigation.

[128]  K. Williams,et al.  Mechanisms by which lipoprotein lipase alters cellular metabolism of lipoprotein(a), low density lipoprotein, and nascent lipoproteins. Roles for low density lipoprotein receptors and heparan sulfate proteoglycans. , 1992, The Journal of biological chemistry.

[129]  R. Lees,et al.  Time course of 125I-labeled LDL accumulation in the healing, balloon-deendothelialized rabbit aorta. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[130]  J. Breslow,et al.  Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis , 1989, Nature.

[131]  Hao Li,et al.  Lack of apoA-I is not associated with increased susceptibility to atherosclerosis in mice. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[132]  A. Gown,et al.  Human atherosclerosis. III. Immunocytochemical analysis of the cell composition of lesions of young adults. , 1992, The American journal of pathology.

[133]  Chisolm Gm Oxidized lipoproteins and leukocyte-endothelial interactions: growing evidence for multiple mechanisms. , 1993 .

[134]  S. Weinbaum,et al.  Transendothelial Transport of Low Density Lipoprotein in Association with Cell Mitosis in Rat Aorta , 1989, Arteriosclerosis.

[135]  G. Bondjers,et al.  Effect of arterial proteoglycans and glycosaminoglycans on low density lipoprotein oxidation and its uptake by human macrophages and arterial smooth muscle cells. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[136]  T. Carew,et al.  Measurement in vivo of irreversible degradation of low density lipoprotein in the rabbit aorta. Predominance of intimal degradation. , 1984, Arteriosclerosis.

[137]  B. Ames,et al.  The oxidation of blood plasma and low density lipoprotein components by chemically generated singlet oxygen. , 1993, The Journal of biological chemistry.

[138]  J. Randolph,et al.  Bacterial lipopolysaccharide has structural similarity to ceramide and stimulates ceramide-activated protein kinase in myeloid cells. , 1994, The Journal of biological chemistry.

[139]  D. Steinberg,et al.  Role of oxidized low density lipoprotein in atherogenesis. , 1991, The Journal of clinical investigation.

[140]  R. Ross,et al.  ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[141]  J. Loscalzo,et al.  Lipoprotein(a), fibrin binding, and plasminogen activation. , 1990, Arteriosclerosis.

[142]  P. Görög,et al.  Nifedipine inhibits accumulation of LDL and cholesterol in the aorta of the normocholesterolemic rabbit. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[143]  W. Wagner,et al.  Metabolism and turnover of cell surface-associated heparan sulfate proteoglycan and chondroitin sulfate proteoglycan in normal and cholesterol-enriched macrophages. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[144]  R. Mulligan,et al.  Characterization of ryudocan glycosaminoglycan acceptor sites. , 1994, The Journal of biological chemistry.

[145]  W. Wagner,et al.  A Proposed Structure of Chondroitin 6‐Sulfate Proteoglycan of Human Normal and Adjacent Atherosclerotic Plaque , 1986, Arteriosclerosis.

[146]  S. Srinivasan,et al.  Human monocyte-derived macrophages bind low-density-lipoprotein-proteoglycan complexes by a receptor different from the low-density-lipoprotein receptor. , 1993, The Biochemical journal.

[147]  B. Nordestgaard,et al.  Atherosclerosis and arterial influx of lipoproteins. , 1994, Current opinion in lipidology.

[148]  D. Carey,et al.  Regulated expression of syndecan in vascular smooth muscle cells and cloning of rat syndecan core protein cDNA. , 1992, The Journal of biological chemistry.

[149]  V. Tertov,et al.  Intracellular cholesterol accumulation is accompanied by enhanced proliferative activity of human aortic intimal cells. , 1988, Tissue & cell.

[150]  A. J. Valente,et al.  Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[151]  T. McCaffrey,et al.  Macrophage and foam cell release of matrix-bound growth factors. Role of plasminogen activation. , 1993, The Journal of biological chemistry.

[152]  C. Glueck,et al.  Familial hypobetalipoproteinemia. Absence of atherosclerosis in a postmortem study. , 1978, JAMA.

[153]  A. Fogelman,et al.  Lipid accumulation in rabbit aortic intima 2 hours after bolus infusion of low density lipoprotein. A deep-etch and immunolocalization study of ultrarapidly frozen tissue. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[154]  R. Rosenberg,et al.  Molecular cloning and expression of two distinct cDNA-encoding heparan sulfate proteoglycan core proteins from a rat endothelial cell line. , 1992, The Journal of biological chemistry.

[155]  R. Schlegel,et al.  Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[156]  N. Kalant,et al.  Inhibition by serum components of oxidation and collagen-binding of low-density lipoprotein. , 1992, Biochimica et biophysica acta.

[157]  D. Steinberg,et al.  Macrophages and smooth muscle cells express lipoprotein lipase in human and rabbit atherosclerotic lesions. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[158]  A. Chait,et al.  The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells. , 1987, The Journal of biological chemistry.

[159]  L. Sandell,et al.  Differential expression of small chondroitin/dermatan sulfate proteoglycans, PG-I/biglycan and PG-II/decorin, by vascular smooth muscle and endothelial cells in culture. , 1991, The Journal of biological chemistry.

[160]  D. Schwenke,et al.  Accumulation of 125I-tyramine cellobiose-labeled low density lipoprotein is greater in the atherosclerosis-susceptible region of White Carneau pigeon aorta and further enhanced once atherosclerotic lesions develop. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[161]  M. Jauhiainen,et al.  Interaction of lipoprotein(a) with fibronectin and its potential role in atherogenesis. , 1990, European heart journal.

[162]  A. Cardin,et al.  Molecular Modeling of Protein‐Glycosaminoglycan Interactions , 1989, Arteriosclerosis.

[163]  F. Kraemer,et al.  Regulation of macrophage lipoprotein lipase secretion by the scavenger receptor. , 1988, Biochimica et biophysica acta.

[164]  Cholesterol and atherosclerosis: "the new is the old rediscovered". , 1993, The American journal of cardiology.

[165]  Margaret S. Wu,et al.  Low density lipoprotein is protected from oxidation and the progression of atherosclerosis is slowed in cholesterol-fed rabbits by the antioxidant N,N'-diphenyl-phenylenediamine. , 1992, The Journal of clinical investigation.

[166]  P. Carlsson,et al.  Identification of Apo B‐100 Segments Mediating the Interaction of Low Density Lipoproteins with Arterial Proteoglycans , 1988, Arteriosclerosis.

[167]  T. Nikkari,et al.  Glycosaminoglycans and Apolipoproteins B and A‐l in Human Aortas: Chemical and Immunological Analysis of Lesion‐Free Aortas from Children and Adults , 1987, Arteriosclerosis.

[168]  A. Scanu,et al.  Lipoprotein (a). Heterogeneity and biological relevance. , 1990, The Journal of clinical investigation.

[169]  M. King,et al.  Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. , 1990, Circulation.

[170]  G. Manley,et al.  Distribution of Mucopolysaccharides in the Human Vascular Tree , 1965, Nature.

[171]  D. Radzioch,et al.  High macrophage lipoprotein lipase expression and secretion are associated in inbred murine strains with susceptibility to atherosclerosis. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[172]  T. Kodama,et al.  Expression of alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein and scavenger receptor in human atherosclerotic lesions. , 1994, The Journal of clinical investigation.

[173]  S. Srinivasan,et al.  Proteoglycans, lipoproteins, and atherosclerosis. , 1991, Advances in experimental medicine and biology.

[174]  P. Libby,et al.  An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[175]  R. Dinerstein,et al.  Ex vivo lipopolysaccharide‐induced interleukiri‐1 secretion from murine peritoneal macrophages inhibited by probucol, a hypocholesterolemic agent with antioxidant properties , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[176]  R. Frants,et al.  Low density lipoprotein receptor internalizes low density and very low density lipoproteins that are bound to heparan sulfate proteoglycans via lipoprotein lipase. , 1993, The Journal of biological chemistry.

[177]  M. Ferguson,et al.  Lipoprotein lipase is synthesized by macrophage-derived foam cells in human coronary atherosclerotic plaques. , 1992, The Journal of clinical investigation.

[178]  G. Bondjers,et al.  Cationic polypeptides modulate in vitro association of low density lipoprotein with arterial proteoglycans, fibroblasts, and arterial tissue. , 1990, Arteriosclerosis.

[179]  J. Campbell,et al.  Glycosaminoglycan synthesis by smooth muscle cells of differing phenotype and their response to endothelial cell conditioned medium. , 1990, Atherosclerosis.

[180]  J. Salonen,et al.  Autoantibody against oxidised LDL and progression of carotid atherosclerosis , 1992, The Lancet.

[181]  J. Esko,et al.  Amino acid determinants that drive heparan sulfate assembly in a proteoglycan. , 1994, The Journal of biological chemistry.

[182]  D K Burns,et al.  Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. , 1994, The Journal of clinical investigation.

[183]  T. Carew,et al.  A comparison of the antiatherogenic effects of probucol and of a structural analogue of probucol in low density lipoprotein receptor-deficient rabbits. , 1994, The Journal of clinical investigation.

[184]  K. Williams,et al.  Lipoprotein lipase and sphingomyelinase synergistically enhance the association of atherogenic lipoproteins with smooth muscle cells and extracellular matrix. A possible mechanism for low density lipoprotein and lipoprotein(a) retention and macrophage foam cell formation. , 1993, The Journal of biological chemistry.

[185]  J. Breslow,et al.  Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[186]  M. Thubrikar,et al.  Distribution of low density lipoprotein in the branch and non-branch regions of the aorta. , 1992, Atherosclerosis.

[187]  R. Poston,et al.  Increase in the adhesion molecule P-selectin in endothelium overlying atherosclerotic plaques. Coexpression with intercellular adhesion molecule-1. , 1994, The American journal of pathology.

[188]  W D Wagner,et al.  A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1994, Circulation.

[189]  M. Cybulsky,et al.  Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. , 1992, The Journal of clinical investigation.

[190]  M. Chang,et al.  Long-term nicotine exposure increases aortic endothelial cell death and enhances transendothelial macromolecular transport in rats. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[191]  M. Alavi,et al.  Lipoprotein-proteoglycan complexes from injured rabbit aortas accelerate lipoprotein uptake by arterial smooth muscle cells. , 1994, Atherosclerosis.

[192]  D. Alonso,et al.  Effect of endothelium on glycosaminoglycan accumulation in injured rabbit aorta. , 1983, The American journal of pathology.

[193]  A. J. Valente,et al.  Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. , 1991, The Journal of clinical investigation.

[194]  R. Ross The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.

[195]  D. Steinberg,et al.  Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[196]  C F Dewey,et al.  Regulation of adenine nucleotide concentration at endothelium-fluid interface by viscous shear flow. , 1993, Biophysical journal.

[197]  G. Bondjers,et al.  Interaction of LDL with human arterial proteoglycans stimulates its uptake by human monocyte-derived macrophages. , 1990, Journal of lipid research.

[198]  J. Viikari,et al.  Effect of repeated endotoxin treatment and hypercholesterolemia on preatherosclerotic lesions in weaned pigs. Part II. Lipid and glycosaminoglycan analysis of intima and inner media. , 1988, Atherosclerosis.

[199]  S. Halvorsen,et al.  Does Lp(a) lipoprotein inhibit the fibrinolytic system? , 1992, Thrombosis research.

[200]  S. Srinivasan,et al.  Lipoprotein-proteoglycan complexes from atherosclerotic lesions promote cholesteryl ester accumulation in human monocytes/macrophages. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[201]  T. Koschinsky,et al.  A MECHANISM BY WHICH HIGH-DENSITY LIPOPROTEINS MAY SLOW THE ATHEROGENIC PROCESS , 1976, The Lancet.

[202]  P. Davies,et al.  Hemodynamic forces and vascular cell communication in arteries. , 1992, Archives of pathology & laboratory medicine.

[203]  A. Ooshima,et al.  Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[204]  I. Tabas,et al.  Cholesterol loading of macrophages leads to marked enhancement of native lipoprotein(a) and apoprotein(a) internalization and degradation. , 1993, The Journal of biological chemistry.

[205]  D. Steinberg,et al.  Prevention of low density lipoprotein aggregation by high density lipoprotein or apolipoprotein A-I. , 1990, Journal of lipid research.

[206]  S. Humphries,et al.  Associations between lipoprotein lipase gene polymorphisms and plasma correlations of lipids, lipoproteins and lipase activities in young myocardial infarction survivors and age-matched healthy individuals from Sweden. , 1992, Atherosclerosis.

[207]  D. Carey,et al.  Molecular cloning and characterization of N-syndecan, a novel transmembrane heparan sulfate proteoglycan , 1992, The Journal of cell biology.

[208]  N. Simionescu,et al.  Pathobiochemical changes of the arterial wall at the inception of atherosclerosis. , 1993, Current topics in pathology. Ergebnisse der Pathologie.

[209]  J. Cassiman,et al.  Cell surface heparan sulfate proteoglycans from human vascular endothelial cells. Core protein characterization and antithrombin III binding properties. , 1992, The Journal of biological chemistry.

[210]  R. Phair,et al.  Cellular calcium and atherosclerosis: a brief review. , 1988, Cell calcium.

[211]  M. Merrilees,et al.  Endothelial cell stimulation of smooth muscle glycosaminoglycan synthesis can be accounted for by transforming growth factor beta activity. , 1990, Atherosclerosis.

[212]  C. Zarins,et al.  Preservation and structural adaptation of endothelium over experimental foam cell lesions. Quantitative ultrastructural study. , 1989, Arteriosclerosis.

[213]  D. Steinberg,et al.  Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[214]  D. L. Fry,et al.  Local intimal-medial uptakes of 125I-albumin, 125I-LDL, and parenteral Evans blue dye protein complex along the aortas of normocholesterolemic minipigs as predictors of subsequent hypercholesterolemic atherogenesis. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[215]  P. Edwards,et al.  Rabbit beta-migrating very low density lipoprotein increases endothelial macromolecular transport without altering electrical resistance. , 1986, The Journal of clinical investigation.

[216]  T Zand,et al.  Lipid deposition and intimal stress and strain. A study in rats with aortic stenosis. , 1991, The American journal of pathology.

[217]  H. Hoff,et al.  Insoluble complex formation of lipoprotein (a) with low density lipoprotein in the presence of calcium ions. , 1993, The Journal of biological chemistry.